- Filed
- Mar 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 13, 2026 | 9.09M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 13.15M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 9.23M sh |
| Capex | FY 2025 · Dec 31, 2025 | $280.15K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | $1.08M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$3.02M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $5.6M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $10.59M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $18.19M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $11.9M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $20.13M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $7.32M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $3.54M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $7.85M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $3.97M |
| Current Assets | FY 2025 · Dec 31, 2025 | $11.47M |
| Current Assets | FY 2025 · Dec 31, 2024 | $11.24M |
| Total Assets | FY 2025 · Dec 31, 2025 | $26.04M |
| Total Assets | FY 2025 · Dec 31, 2024 | $15.87M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.15 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$0.91 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$0.15 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$0.91 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $10.55M |
| Sga Expense restated | FY 2025 · Dec 31, 2024 | $4.86M |
| Net Income | FY 2025 · Dec 31, 2025 | −$1.96M |
| Net Income | FY 2025 · Dec 31, 2024 | −$8.43M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$4.72M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$5.12M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $11.27M |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $262.89K |
| Stock Repurchased | FY 2025 · May 8, 2025 | $400K |